The Association Between Body Mass Index and Anti-Müllerian Hormone Value in Women with or Without Polycystic Ovary Syndrome
Abstract
Background: Anti-Müllerian hormone (AMH) is widely used as a predictor of ovarian reserve. Although increased body weight is associated with reduced fertility, the relationship between Body Mass index (BMI) and AMH remains inconclusive, limiting its accurate interpretation. Objectives: This study aims to investigate the association between serum AMH levels and BMI among individuals with and without polycystic ovarian syndrome (PCOS). Methods: This cross-sectional, single-center study analyzed 522 patients who attended an Obstetrics and Gynecology clinic in Al-Diwaniyah, Iraq, from January 2022 to October 2024. Patients were categorized based on BMI into two groups: Those with a BMI ≥ 30 kg/m2 and those with a BMI < 30 kg/m2. The PCOS diagnosis was based on the International Classification of Diseases, 10th Revision (ICD-10) code and the Rotterdam Criteria. Inclusion criteria required female participants to be at least 19 years old with documented BMI and AMH test results within the study period. Exclusion criteria included diabetes, systemic diseases, galactorrhea, endocrine disorders, metformin intake, and contraceptive use within the past four weeks. Statistical Analysis: The chi-square test, receiver operating characteristic (ROC) curve, one-way analysis of variance (ANOVA), independent samples t-test, and Pearson correlation test were used for data analysis. A P-value of ≤ 0.05 was considered statistically significant. Results: The mean BMI of the PCOS group was…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 522 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.